Your browser doesn't support javascript.
loading
RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells.
Durand, Sébastien; Bruelle, Marion; Bourdelais, Fleur; Bennychen, Bigitha; Blin-Gonthier, Juliana; Isaac, Caroline; Huyghe, Aurélia; Martel, Sylvie; Seyve, Antoine; Vanbelle, Christophe; Adrait, Annie; Couté, Yohann; Meyronet, David; Catez, Frédéric; Diaz, Jean-Jacques; Lavial, Fabrice; Ricci, Emiliano P; Ducray, François; Gabut, Mathieu.
Afiliación
  • Durand S; Cancer Initiation and Tumoral Cell Identity (CITI) Department. Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286, Université Claude Bernard Lyon I, Centre Léon Bérard, Lyon, France.
  • Bruelle M; Institut Convergence Plascan, Lyon, France.
  • Bourdelais F; Labex Dev2Can, Lyon, France.
  • Bennychen B; Cancer Initiation and Tumoral Cell Identity (CITI) Department. Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286, Université Claude Bernard Lyon I, Centre Léon Bérard, Lyon, France.
  • Blin-Gonthier J; Cancer Initiation and Tumoral Cell Identity (CITI) Department. Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286, Université Claude Bernard Lyon I, Centre Léon Bérard, Lyon, France.
  • Isaac C; Institut Convergence Plascan, Lyon, France.
  • Huyghe A; Labex Dev2Can, Lyon, France.
  • Martel S; Inovarion, 75005, Paris, France.
  • Seyve A; Dept. of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, K1H 8M5, Canada.
  • Vanbelle C; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, K1A 0R6, Canada.
  • Adrait A; Laboratoire de Biologie et de Modélisation de la Cellule, ENS de Lyon, CNRS UMR 5239, Inserm U1293, Lyon, France.
  • Couté Y; Cancer Initiation and Tumoral Cell Identity (CITI) Department. Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286, Université Claude Bernard Lyon I, Centre Léon Bérard, Lyon, France.
  • Meyronet D; Institut Convergence Plascan, Lyon, France.
  • Catez F; Labex Dev2Can, Lyon, France.
  • Diaz JJ; Cancer Initiation and Tumoral Cell Identity (CITI) Department. Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286, Université Claude Bernard Lyon I, Centre Léon Bérard, Lyon, France.
  • Lavial F; Institut Convergence Plascan, Lyon, France.
  • Ricci EP; Labex Dev2Can, Lyon, France.
  • Ducray F; Equipe labellisée la Ligue contre le cancer, Lyon, France.
  • Gabut M; Cancer Initiation and Tumoral Cell Identity (CITI) Department. Cancer Research Centre of Lyon (CRCL) INSERM 1052, CNRS 5286, Université Claude Bernard Lyon I, Centre Léon Bérard, Lyon, France.
Nat Commun ; 14(1): 356, 2023 01 23.
Article en En | MEDLINE | ID: mdl-36690642
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Pluripotentes / Células Madre Embrionarias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Pluripotentes / Células Madre Embrionarias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Francia